Serotonergic functions in arousal and motor activity

Behavioural Brain Research

Volumn 73, Issue 1-2, 1995, Pages 31-35

  Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

3,4 Methylenedioxymethamphetamine (MDMA); Fenfluramine; Locomotor; Serotonin; Serotonin release

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 5 METHOXY 3 (1,2,3,6 TETRAHYDRO 4 PYRIDYL) 1H INDOLE; AMPHETAMINE; AMPHETAMINE DERIVATIVE; CHLORAMPHETAMINE; DOPAMINE; ETRYPTAMINE; FENFLURAMINE; SEROTONIN; SEROTONIN 1 RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; AROUSAL; CONFERENCE PAPER; CONTROLLED STUDY; LOCOMOTION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; AROUSAL; MOTOR ACTIVITY; SEROTONIN;

EID: 0009552229     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/0166-4328(96)00065-4     Document Type: Article

References (45)

1. A proposed animal model for hallucinogens based on LSD's effects on patterns of exploration in rats
2. Fenfluramine-induced suppression of food intake and locomotor activity is differentially altered by the selective type A monoamine oxidase inhibitor clorgyline
3. Serotonin release contributes to the stimulant effects of 3,4-methylenedioxymethamphetamine in rats
4. Amphetamine derivatives produce locomotor hyperactivity by acting as indirect serotonin agonists
5. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamohetamine and a serotonin 5HT-1B agonist
6. Serotonin 5-HT-1-like receptors mediate hyperactivity in rats induced by 3,4-methylenedioxymethamphetamine
7. Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release
8. Effects of hallucinogens on unconditioned behaviors in animals
9. The effect of parachlorophenylalanine on spontaneous locomotor activity in the rat
10. Serotonin depletions induced by 5,7-dihydroxytryptamine alter the response to amphetamine and the habituation of locomotor activity in rats
11. Heterogenous functions of discrete serotonergic pathways in brain
12. Behavioral pharmacology of ring-substituted amphetamine analogs
13. Serotonin receptor involvement in an animal model of the acute effects of hallucinogens
14. Multivariate and non-linear approaches to the characterization of drug effects on the locomotor and investigatory behavior of rats
15. Behavioral studies following lesions of the mesolimbic and mesostriatal serotonergic pathways
16. Effects of serotonergic lesions on investigatory responding by rats in a holeboard
17. Multivariate assessment of locomotor behavior: Pharmacological and behavioral analyses
18. Stimulant and hallucinogenic behavioral profiles of 3,4-methylenedioxymethamphetamie and N-ethyl-3,4-methylenedioxyamphetamine in rats
19. 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-releasing effect of 3,4-methylenedioxymethamphetamine and related agents
20. Behavioral effects of 5,7-dihydroxytryptamine lesions of ascending 5-hydroxytryptamine pathways
21. Dreams and hallucinations: A common mechanism mediating their phenomenological similarities
22. Postsynaptic serotonergic action of hallucinogens
23. Differential behavioral and neurochemical effects following lesions of the dorsal or median raphe nuclei in rats
24. 3H]dopamine release from superfused rat brain slices
25. Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative having MDMA-like properties in rats
26. Cross-tolerance studies of serotonin receptors involved in behavioral effects of LSD in rats
27. Serotonin depletion causes long-term reduction of exploration in the rat
28. Some behavioral effects of serotonin depletion depend on method: a comparison of 5,7-dihydroxytryptamine, p-chlorophenylalanine, p-chloroamphetamine, and electrolytic raphe lesions
29. 3,4-methylenedioxyamphetamine (MDA) analogues exhibit differential effects on synaptosomal release of 3H-dopamine and 3H-5-hydroxytryptamine
30. Effects of 5HT-1A agonists on locomotor and investigatory behaviors in rats differ from those of hallucinogens
31. Derivatives of 1-(1,3-benzodioxol-5-yl)-2-butanamine: representatives of a novel therapeutic class
32. Distinct functions for dopamine and serotonin in locomotor behavior: evidence using the 5HT1 agonist RU24969 in globus pallidus-lesioned rats
33. Tolerance to the serotonin 5-HT1 agonist RU24969 and effects on dopaminergic behavior
34. Drug discrimination studies with MDMA and amphetamine
35. The effects of MDMA and other methylenedioxy substituted phenylalkylamines on the structure of rat locomotor activity
36. The relation of central 5-HT1A and 5-HT2 receptors: Low dose agonist-induced selective tolerance in the rat
37. Serotonin 5-HT1B receptor activation mimics behavioral effects of presynaptic serotonin release
38. Effects of fluoxetine or d-fenfuramine on serotonin release from, and levels in, rat frontal cortex
39. In vitro and in vivo neurochemical effects of methylenedioxymethamphetamine on striatal monoaminergic systems in the rat brain
40. Raphe unit activity in freely moving cats is altered by manipulations of central but not peripheral motor systems
41. Pharmacological analysis of the behavioral and thermoregulatory effects of the putative 5-HT-1B receptor agonist, RU 24969, in the rat
42. Raphe unit activity in freely moving cats: Correlation with level of behavioral arousal
43. Pharmacological studies on the serotonergic and nonserotonin-mediated stimulation of prolactin and corticosterone secretion by fenfluramine
44. 5-HT2 mediation of acute behavioral effects of hallucinogens in rats
45. Central nervous system effects of fenfluramine hydrochloride